Malin Corporation | MLC - Ordinary Share Capital


Malin Corporation reported EUR200K in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
ALKERMES USD 165.61M 503K Dec/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Eurofins Scientific SE EUR 177.9M 0 Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Revvity USD 113.38M 2.7M Dec/2025
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025